Sourcing a growing Biotech in Philadelphia with 24 top-notch professionals

The Challenge

Working as a preferred partner across their translational team Warman O’Brien were tasked with assisting a growing biotech from series A funding through to their IPO during an exciting expansion stage. This has been an ongoing project with the majority of hiring during late 2021 – 2022. Through briefing with both Talent Acquisition and Line Managers, we have been responsible for finding candidates for multiple flexible briefs, across data science, bioinformatics, biostats, scientific and QA/QC. The client is focusing on developing novel cancer therapeutics that are the first of their kind, as such, there are not many candidates with the experience they were looking for on the market.
Sourcing a growing Biotech in Philadelphia with 24 top-notch professionals


24 hires

24 hires

Average time to hire 5 weeks

Average time to hire 5 weeks

Development of a novel personalised cancer therapeutics

Development of a novel personalised cancer therapeutics


The Solution

Warman O’Brien mapped out the UK market across the required areas, specifically focusing on candidates who had an experience in areas where skillsets would be transferable, such as; Machine Learning, DNA Sequencing, CRISPR, and gene editing. Each role required a proactive search of passive candidates, the majority of which came from our existing network. Where appropriate, detailed shortlists were provided before moving to the initial screening.

The Results

3 x Bioinformatics Specialists

5 x Scientific Researchers

2 x TMF Focused Clinical Research Specialists

2 x Project Management Clinical Operations Specialists

2 x Clinical Research Associates

7 x Data Scientists / Statisticians

Get in touch

Whether you're looking to scale your team or grow your own career, we're here to support you.

Contact Us

Apply today

Ready for a career move? Click below to find a role that suits you the best.

Job Search
© Warman O'Brien 2023
Site by Venn